Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9.670 KRW | -1,73 % | -4,64 % | +3,09 % |
Resumen de negocios
Número de empleados: 308
Ventas por actividad
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals Manufacturing
74,7
%
| 99 593 | 75,5 % | 105 549 | 74,7 % | +5,98 % |
Pharmaceutical Wholesaler
15,7
%
| 23 225 | 17,6 % | 22 144 | 15,7 % | -4,65 % |
Cosmetics and Medical Device Manufacturing
4,9
%
| 5 034 | 3,8 % | 6 891 | 4,9 % | +36,87 % |
Pharmaceutical Raw Material Manufacturing
4,7
%
| 3 958 | 3,0 % | 6 694 | 4,7 % | +69,14 % |
Medical Information System
0,1
%
| 102 | 0,1 % | 81 | 0,1 % | -20,03 % |
Ventas por región
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
South Korea
91,0
%
| 117 086 | 88,8 % | 128 628 | 91,0 % | +9,86 % |
Germany
4,9
%
| 5 034 | 3,8 % | 6 891 | 4,9 % | +36,87 % |
Myanmar/Cambodia
1,5
%
| 2 105 | 1,6 % | 2 117 | 1,5 % | +0,59 % |
Vietnam
1,0
%
| 640 | 0,5 % | 1 406 | 1,0 % | +119,61 % |
Other
0,9
%
| 2 268 | 1,7 % | 1 226 | 0,9 % | -45,95 % |
Ecuador/Bolivia
0,8
%
| 1 162 | 0,9 % | 1 085 | 0,8 % | -6,58 % |
China
0,0
%
| 3 617 | 2,7 % | 6 | 0,0 % | -99,84 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15/12/85 |
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01/02/08 |
Jae-Seong Na
DFI | Director of Finance/CFO | 55 | 01/02/93 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/10/08 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01/03/89 |
Shin-Won Bang
SAM | Sales & Marketing | 54 | - |
Tae-Hoon Kim
HRO | Human Resources Officer | 49 | 01/05/18 |
Boon-Yeon Ahn
PRN | Corporate Officer/Principal | 59 | 01/05/92 |
Nam-Soo Han
PRN | Corporate Officer/Principal | 68 | - |
Shin-Bae Ji
PRN | Corporate Officer/Principal | 60 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01/02/08 |
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15/12/85 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01/03/89 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/10/08 |
Jong-Il Kim
BRD | Director/Board Member | 62 | 24/03/17 |
Hye-Seon Jeong
BRD | Director/Board Member | 63 | 01/03/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 18 616 650 | 12 091 717 ( 64,95 %) | 1 100 000 ( 5,909 %) | 64,95 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
1 100 000 | 5.91% | 8 810 505 $ |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,09 % | 127 M | |
+16,34 % | 79,03 mil M | |
+8,19 % | 8778,57 M | |
-16,33 % | 4829,5 M | |
+51,22 % | 4651,36 M | |
+2,18 % | 3892,24 M | |
+20,51 % | 2337,55 M | |
-26,79 % | 2175,56 M | |
+15,12 % | 2112,42 M | |
-36,56 % | 1995,14 M |
- Bolsa de valores
- Acciones
- Acción A067080
- Empresa DAE HWA Pharmaceutical Co., Ltd.